Patent · US Active

Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase

US8263777B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

Vertex Pharmaceuticals Incorporated · US

Inventors

David J. Lauffer · Saline, US
Pan Li · Lexington, US
Stefanie Roeper · Medford, US
Shereen Ibrahim · Cambridge, US
Anuj K. Kuldipkumar · Medford, US
Yi-Qun Shi · East Brunswick Township, US
David B. Miller, JR. · Waltham, US

Key dates

Filing date	May 24, 2011
Grant date	Sep 11, 2012
Priority date	—
Expiry date	May 24, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to anhydrous and hydrated forms of Compound 1, which are useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising compounds of formula I and methods of using the compositions in the treatment of proliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.